Clinical Trial

A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs

Name: A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs — clinical trial record (NCT07069569)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a randomized, open-label, multicenter phase II study to evaluate the efficacy and safety of AHB-137 injection in combination with other hepatitis B drugs in participants with HBeAg-negative CHB treated with NAs.

Protocol Amendment History 1 change

notable Trial sites expanded: 1 -> 14 locations 2026-07-30

Trial Details

NCT Number	NCT07069569
Lead Sponsor	Ausper Biopharma Co., Ltd.
Conditions	Chronic Hepatitis B
Enrollment	200 participants
Start Date	2025-06-08
Primary Completion	2027-07-15 (estimated)
Study Completion	2028-01-15 (estimated)
Updated on ClinicalTrials.gov	2026-07-29